(Q38837587)

6 September 2017

title

Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms (English)

1 reference

6 September 2017

1 reference

1

Sarah K Baird

1 reference

6 September 2017

Angela Rigopoulos

2

1 reference

6 September 2017

Diana Cao

3

1 reference

6 September 2017

Laura Allan

4

1 reference

6 September 2017

Christoph Renner

5

1 reference

6 September 2017

Fiona E Scott

6

1 reference

6 September 2017

Andrew M Scott

7

1 reference

6 September 2017

language of work or name

1 reference

5 September 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

20

1 reference

6 September 2017

issue

11

1 reference

6 September 2017

page(s)

1483-1498

1 reference

https://scigraph.springernature.com/pub.10.1007/s10495-015-1166-5

6 September 2017

exact match

0 references

cites work

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Over-expression of fibroblast activation protein alpha increases tumor growth in xenografts of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

TGF-beta induces fibroblast activation protein expression; fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

A methodology for analysis of tissue sulfhydryl components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Interruption of mitochondrial complex IV activity and cytochrome c expression activated O₂·⁻-mediated cell survival in silibinin-treated human melanoma A375-S2 cells via IGF-1R-PI3K-Akt and IGF-1R-PLC γ-PKC pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Fibroblast activation protein-α promotes ovarian cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Apoptosis in cancer therapy: crossing the threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-015-1166-5

10.1007/S10495-015-1166-5

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference